Look, Ma, no risk factors! (Just risk)
The British medical journal The Lancet published a study this week of the success of a new obesity drug, rimonabant. It’s a double-action substance, simultaneously telling the brain to shut up when it says, “I’m hungry” and also forcing fat cells to stop producing the nasty chemicals that elevate cardiovascular risk factors. (Read the BBC [...]
